Navigation Links
Veran Medical Publishes Lung Cancer Patient Management Study
Date:7/11/2014

ST. LOUIS, July 11, 2014 /PRNewswire/ -- Veran Medical Technologies, a U.S. based medical device company, announced today the positive, cost-effective final results for the initial study of its innovative SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy study results support the use of a percutaneous approach to biopsy when a traditional bronchoscopic method is not possible.  Hospitals, patients and physicians experience positive financial outcomes when more can be accomplished in one procedure.  This study demonstrated a hospital savings of $693,327 per 200 lung cancer screening patients with positive findings.1

Photo - http://photos.prnewswire.com/prnh/20140710/126171 

Photo - http://photos.prnewswire.com/prnh/20140710/126170

In addition to the study, a SPiNPerc clinical trial is in process at Johns Hopkins Hospital in Baltimore, Maryland.  An interim analysis has shown the procedure to be feasible and safe with final data to be published in the near future.  Dr. Lonny Yarmus, Clinical Chief of the Division of Pulmonary and Critical Care at Johns Hopkins, stated that, "Veran's SPiNPerc technology gives me the option of an endobronchial and percutaneous approach to detect lung cancer.  Many of my patients in the study previously would have needed additional visits to get an answer."

Rob Powers, Veran's Global Vice President of Marketing, noted that, "ENB has been on the market for nearly 10 years and the five-year survival rate remains an unacceptable 15-16%.  We are providing both an advanced ENB system and innovations like SPiNPerc that have the potential to impact survival." Powers went on to add, "setting up a comprehensive lung cancer screening program is important.  The SPiNPerc procedure clearly offers a cost effective new patient care pathway for those patients with a suspicious lesion found on their CT scan."

The Lung Cancer Management study was written by Dr. K. Adam Lee, Dr. Abhijit A. Raval and Leah Amir. Practice points conclude that "having both navigation bronchoscopy and computed tomography fine-needle aspiration ready on the same platform allows an easy transition from one procedure to the other if the first approach fails."

Dr. K. Adam Lee, thoracic surgeon and expert in the SPiNPerc procedure, said that, "besides the cost effectiveness of SPiNPerc, Veran's technology gives me every tool I need to diagnosis and treat my patient in the best way, which demonstrates the practice of good medicine."

About Veran Medical Technologies. Veran Medical Technologies is a privately held soft tissue navigation company based in the USA, focused on the early diagnosis of cancer.  Multiple specialties use Veran's electromagnetic navigation platform to enhance hospital oncology programs.  The technology is used to assist with lung, kidney and liver procedures endobronchially or percutaneously for biopsies, ablations, drainages and more.   Veran Medical Technologies is headquartered in St. Louis, MO.

Veran Medical Technologies Media Contact

Michelle Kalz, Marketing Manager | 314.659.8500 | www.veranmedical.com

1 Lung Cancer Management, Lee, Raval, et. al 2014


'/>"/>
SOURCE Veran Medical Technologies
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Technologies Welcomes New Member to its Board of Directors
2. CVBT-Aktionäre stimmen für Veränderungen
3. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
4. CIOs von GlaxoSmithKline und British American Tobacco als Referenten auf führender Strategie-Veranstaltung für Unternehmensmobilität
5. Marken richtet branchenspezifische Diskussionsveranstaltung in Mexiko-Stadt aus
6. Noverant Launches Major Learning Management System Upgrade
7. University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services
8. Representative Patrick Kennedy visits Mobergs medical device facility to discuss improvement in brain injury care
9. Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment
10. Intellectual Property Insurance for Medical-related Products and Services
11. Tegra Medical Appoints New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
(Date:4/24/2017)... ... 24, 2017 , ... Labs often perform the same operations ... operators and management to assess these processes with a critical eye—particularly in the ... , Created with the help of both internal and external process experts, ...
(Date:4/24/2017)... New York, NY (PRWEB) , ... April 24, ... ... students in 72 countries clearly shows that over the last decade, student well-being ... have ticked all the boxes of formal education, join the Islamic State to ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to using ... Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 years, ... USA, and former member of the American Association of Christian Counselors. Rachel studied ...
(Date:4/24/2017)... ... 2017 , ... Miami Periodontist and Dental Implant ... Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in Miami Beach ... Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This annual symposium ...
Breaking Medicine News(10 mins):